COO at RJ Lee Group
RJ Lee Group, Inc. and SteelFusion Clinical Toxicology Laboratory, LLC Partner to Test Shell Employees for COVID-19 at the Monaca, Beaver County, PA Ethane Cracker Facility
RJ Lee Group, Inc. and SteelFusion have developed a local partnership to test Shell employees for COVID-19 at the Beaver County (PA) Ethane Cracker Facility. An onsite COVID-19 laboratory was developed to potentially eliminate COVID-19 exposure and outbreaks as employees return to the worksite throughout 2020. RJ Lee Group conceptualized, designed, and built the laboratory, and currently manages data integration. SteelFusion has provided their clinical and safety expertise and developed the Standard Operating Procedures to meet the required guidelines according to their Clinical Laboratory Improvement Amendments Certification.
Viral test results are reported to the employer within hours, allowing all employees with negative test results to safely return to work that same day. To date, Shell has returned 3,700 employees and continues to add more than 300 employees weekly, since the laboratory became fully operational in July 2020. Due to government restrictions, Shell had to furlough all employees considered non-essential in March through April 2020. Since the PA Department of Health granted approval of the onsite COVID-19 laboratory, the workforce at the cracker plant is approaching its pre-COVID-19 closure capacity.
Having this innovative, onsite laboratory, allows large-scale construction and energy companies to continue to operate safely relative to COVID-19. This rapid testing measure upgrades COVID-19 responsiveness at the workplace, by integrating sample collection, analysis, tracking, and reporting.
RJ Lee Group is a Pittsburgh-based materials characterization laboratory which employees 200 scientists, engineers and lab technicians.
SteelFusion Clinical Toxicology Laboratory is a woman-owned business based in Monessen, PA that offers rapid clinical, forensic, and veterinary toxicology services. They specialize in oral fluid and urine for the detection and quantification of illicit and prescription drugs.
SteelFusion Clinical Toxicology Laboratory, LLC CEO, Amy J. Reisinger, has been nominated for the prestigious ATHENA Award.
The Greater Pittsburgh ATHENA Award and ATHENA Young Professional Award recognizes exceptional women who demonstrate excellence in their profession, contribute to their community, and help other women and/or girls to succeed through mentorship.
“I am honored to be nominated for this prestigious award for women. As founder of a woman-owned business I can speak first-hand about how difficult it is for women to succeed in business and I always share my experience to help other women succeed.” – Amy Reisinger remarks about this unexpected achievement.
Throughout her entire career, and in her personal life, Amy has strived to give back to the community while always mentoring other women to grow, learn and succeed.
She has quickly become a pioneering beacon in the toxicology industry. Her drive to find new solutions while keeping an optimistic, high-energy attitude has proven that great things can always be accomplished.
“Amy is a remarkable woman and she will blow them away!” says John W. Manzetti - EXECUTIVE CHAIRMAN - SteelFusion Clinical Toxicology Laboratory, LLC. “Her achievements, mostly on her own, have been remarkable. Who gets 4 patents issued each in months versus years while starting a new business in clinical toxicology from scratch?”
The ATHENA review process includes interviews by a Pittsburgh Technology Council team of judges.
The awards will be held on Friday September 11th and is a virtual event. Be sure to sign-up and give support to Amy and all her efforts.
Do not forget to congratulate Amy on this tremendous recognition on the SteelFusion Facebook page!
The Drug Enforcement Administration’s National Forensic Laboratory Information System (NFLIS) is pleased to release the NFLIS-Drug 2019 Midyear Report, which is available here.
The NFLIS-Drug 2019 Midyear Report presents results of drug cases submitted to State and local laboratories from January 2019 through June 2019 that were analyzed by September 30, 2019. Data from Federal laboratories are also presented.
We wish to thank the more than 280 Federal, State, and local laboratories that contributed information and made this publication possible. We encourage all laboratories not currently participating in the program to join the NFLIS partnership.
Other NFLIS publications are also available for download on the NFLIS Reports Page.
NFLIS Program Contact
NFLIS Program Officer
Drug Enforcement Administration
Diversion Control Division
8701 Morrissette Drive
Springfield, VA 22152
The Other Epidemic
To our clients and business partners:
We hope you are all safe and weathering this new way of life. This article reminded me that our “other epidemic” lives on and we need to be mindful that the work we do every day is meaningful to our population who are addicted and their families.
There is a lot more to do and TeamFusion stands ready to help lead the way.
Let’s keep up the great work.
All the best from TeamFusion.
Amy's Book Release (Pre-Order)